Health ❯ Healthcare ❯ Clinical Trials

Phase II Trials

Randomized Controlled Trials FIREFLY-1 Study Patient Outcomes IDeate-Lung01 Trial COCOON Trial Exercise Interventions Atezolizumab Approval Ibezapolstat Efficacy Gene Therapy Trials Idiopathic Pulmonary Fibrosis Immunotherapy Small Cell Lung Cancer Desensitization Techniques Elraglusib Sorfequiline Study Combination Therapy Weight Management EGFR Inhibitors HLX-1502 Phase III Trials Drug Efficacy Biomarkers Efficacy and Safety Drug Comparison Studies SOLACE2 Trial Randomized Trials TAR-200 Study SunRISe-1 Trial CLEVER Trial CRITICS-II Trial Safety and Efficacy Zemcelpro Trials Weight Loss Medications NOBILITY Study CheckMate-744 Weight Loss Drugs

Exercise Beats Ibuprofen in Early Trial for Chemo Brain

The early findings warrant larger Phase III tests before routine use.

FDA Grants Priority Review to Ifinatamab Deruxtecan for Pretreated Small Cell Lung Cancer

PrimeC Shows Safety and Potential Benefit in ALS Phase 2b as FDA Authorizes Phase 3

EMA Panel Backs Conditional EU Approval for Ojemda in Pediatric Low-Grade Glioma

Sorfequiline Outperforms Standard TB Regimens in Phase 2 Trial

Perioperative Immunotherapy and Liquid Biopsy Show Promise in Resectable Mesothelioma Phase 2 Trial

Pumitamig Shows High Response in First-Line Small Cell Lung Cancer Phase 2

B7-H3 ADC Ifinatamab Deruxtecan Shows 48% Response in Relapsed ES-SCLC in Phase 2

Repurposed Drugs Clear Dormant Breast Cancer Cells in Phase II Trial

EU Grants Conditional Approval to Zemcelpro for Adults Needing Transplants Without a Matched Donor

Everolimus Plus Carboplatin Delays Progression in Advanced Triple-Negative Breast Cancer, Phase 2 Study Shows

FDA Approves Papzimeos as First Therapy for Adult Recurrent Respiratory Papillomatosis

Amgen Advances Monthly Obesity Drug to Phase 3 After 20% Weight Loss in Mid-Stage Trial

AI-Designed Rentosertib Improves Lung Function in Phase IIa IPF Trial